Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.
Open Access
- 1 April 1986
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 163 (4) , 837-855
- https://doi.org/10.1084/jem.163.4.837
Abstract
Based on preliminary evidence indicating that a cell-associated protein of U937 (a human monocyte-like cell line) possessed cofactor activity and was not the C3b/C4b receptor, we sought to further characterize this protein. A sequential four-column purification procedure was devised that includes C3(H2O) affinity chromatography to isolate in reasonable yields and purity a cell-associated protein of U937 and several other human cell lines. Based on its pattern and Mr on SDS-PAGE, acidic pI, and ligand specificity, it is identical to a recently described C3(H2O) or C3b-binding membrane glycoprotein of human PBL and cell lines; having no presently identified function, it was termed gp45-70. After purifying this protein, we determined its functional capabilities and compared them to those of the other complement proteins with regulatory activity directed at components comprising the C3 convertases. This protein was the most efficient (50 times that of H) yet-described cofactor for the I-mediated first cleavage of C3b. It also was a cofactor for the first cleavage of C4b, but was not as efficient as C4bp. The second cleavage of C3b and C4b was not efficiently mediated. It had no ability to accelerate decay in the classical or alternative pathway C3 convertases. Based on this unique activity profile and ability to be surface labeled, we have renamed this molecule membrane cofactor protein (MCP). We suggest that this protein plays a major role in preventing autologous complement activation.Keywords
This publication has 30 references indexed in Scilit:
- Fast and efficient method for detection and estimation of proteinsBiochemical and Biophysical Research Communications, 1985
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- Initiation of complement activationSpringer Seminars in Immunopathology, 1984
- The alternative pathway of complementSpringer Seminars in Immunopathology, 1984
- Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus.The Journal of Experimental Medicine, 1984
- Complement receptor is an inhibitor of the complement cascade.The Journal of Experimental Medicine, 1981
- The biochemistry of complementNature, 1978
- Mechanism of action of the C3b inactivator: Requiremen for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b′)Immunochemistry, 1977
- The NH2-terminal sequences of a subunit of the first component of human complement, Cls, and its activated form, C?FEBS Letters, 1975
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970